3D scaffolds for brain tissue regeneration: architectural challenges.

Biomater Sci

Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.

Published: October 2018

Biomaterials are being utilized to engender biomimetic, pro-regenerative constructs in the form of 3D scaffolds to augment functional neural tissue (brain tissue) repair and regeneration. Tissue engineered three-dimensional (3D) scaffolds have shown various degrees of experimental success, indicating great potential for development as treatment options. However, there is yet to be a 3D scaffold that exhibits consummate results of an effective clinical standard. Critical assessment of the performance of current 3D scaffolds could provide insightful feedback for tailoring future 3D scaffolds towards more promising results. This review provides a critical analysis of current 3D scaffolds for neural tissue engineering. Architectural properties, such as porosity, swelling, and architectural influences, such as design approach and polymeric material choice, were scrutinized for suitability for the desired tissue target properties. Success and shortcomings of various 3D scaffolds were evaluated through the analysis of tissue integration of the 3D scaffold in vivo. Investigations focused on in this review included those: (1) reporting at an in vivo experimental level in animal models, (2) involving polymer-based (natural/synthetic) scaffolds described as possessing a '3D' architecture, (3) targeting brain tissue regeneration (4) published from 2011 onward.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8bm00422fDOI Listing

Publication Analysis

Top Keywords

brain tissue
12
scaffolds
8
tissue
8
tissue regeneration
8
neural tissue
8
current scaffolds
8
scaffolds brain
4
regeneration architectural
4
architectural challenges
4
challenges biomaterials
4

Similar Publications

Trehalose has neuroprotective effects in neurodegenerative diseases. This study aimed to explore the impact of trehalose on traumatic brain injury (TBI) by investigating its role in neuroprotection. The TBI mice model was established utilizing the cortical impact technique followed by trehalose treatment.

View Article and Find Full Text PDF

Microglial polarization and ferroptosis are important pathological features in Alzheimer's disease (AD). Ghrelin, a brain-gut hormone, has potential neuroprotective effects in AD. This study aimed to explore the potential mechanisms by which ghrelin regulates the progression of AD, as well as the crosstalk between microglial polarization and ferroptosis.

View Article and Find Full Text PDF

Non-communicable diseases (NCD) are associated with inflammation and oxidative stress which is further associated with omega-6 (ω6) and omega-3 (ω3) fatty acid (FA) imbalance favoring ω6 FA. By improving ω3 FA consumption, this imbalance can be altered to control NCD. Previously we have reported blends of flaxseed oil (FSO, ω3 FA) with palm olein (PO) or coconut oil (CO) were thermo-oxidatively stable with good storage stability and could improve ω6:ω3 ratio in cell lines.

View Article and Find Full Text PDF

Background: Immunosenescence is the aging of the immune system, which is closely related to the development and prognosis of lung cancer. Targeting immunosenescence is considered a promising therapeutic approach.

Methods: We defined an immunosenescence gene set (ISGS) and examined it across 33 TCGA tumor types and 29 GTEx normal tissues.

View Article and Find Full Text PDF

Pericytes in Glioblastoma: Hidden Regulators of Tumor Vasculature and Therapy Resistance.

Cancers (Basel)

December 2024

Research Group on Tumors of the Central Nervous System, Pathology Department, University of Valencia, 46010 Valencia, Spain.

Glioblastoma IDH wild type (GB), the most common malignant primary brain tumor, is characterized by rapid proliferation, extensive infiltration into surrounding brain tissue, and significant resistance to current therapies. Median survival is only 15 months despite extensive clinical efforts. The tumor microenvironment (TME) in GB is highly specialized, supporting the tumor's aggressive behavior and its ability to evade conventional treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!